Cargando…
Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma.
We analysed 26 metastases from 25 patients with sporadic cutaneous malignant melanoma for alterations in the CDKN2 gene by a combined polymerase chain reaction/single-strand conformation polymorphism (PCR/SSCP)/nucleotide sequencing approach. Eleven alterations (one in exon 1, five in exon 2 and fiv...
Autores principales: | Platz, A., Ringborg, U., Lagerlöf, B., Lundqvist, E., Sevigny, P., Inganäs, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074427/ https://www.ncbi.nlm.nih.gov/pubmed/8562340 |
Ejemplares similares
-
Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.
por: Platz, A., et al.
Publicado: (1996) -
MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008) -
Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations
por: Burke, Laura S., et al.
Publicado: (2013) -
Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
por: Wassberg, C., et al.
Publicado: (1996) -
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)